Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.010
+0.040 (1.35%)
At close: Apr 28, 2026, 4:00 PM EDT
3.035
+0.025 (0.83%)
Pre-market: Apr 29, 2026, 8:22 AM EDT

Anixa Biosciences Cash Flow Statement

Millions USD. Fiscal year is Nov - Oct.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Jan '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21 2020 - 2016
Net Income
-10.31-10.93-12.55-9.81-13.6-12.95
Upgrade
Depreciation & Amortization
0.040.040.040.050.040.06
Upgrade
Loss (Gain) From Sale of Assets
------0.01
Upgrade
Loss (Gain) From Sale of Investments
0.16-0.14----
Upgrade
Stock-Based Compensation
3.553.814.84.746.758.06
Upgrade
Other Operating Activities
-0.09-0.1-0.14-0.12-0.18-0.17
Upgrade
Change in Accounts Receivable
0.170.170.1-0.22-0.03-
Upgrade
Change in Accounts Payable
-0.45-0.360.32-0.060.13-0.1
Upgrade
Change in Other Net Operating Assets
0.060.340.11-0.780.390.17
Upgrade
Operating Cash Flow
-6.88-7.17-7.34-6.21-6.49-4.94
Upgrade
Sale of Property, Plant & Equipment
-----0.04
Upgrade
Investment in Securities
3.394.874.28-5.6-10.73-3.96
Upgrade
Investing Cash Flow
3.394.874.28-5.6-10.73-3.92
Upgrade
Issuance of Common Stock
2.452.393.420.370.4531.57
Upgrade
Repurchase of Common Stock
---0.01---
Upgrade
Other Financing Activities
1.54-0.11----
Upgrade
Financing Cash Flow
3.982.283.420.370.4531.57
Upgrade
Net Cash Flow
0.49-0.030.36-11.45-16.7722.71
Upgrade
Free Cash Flow
-6.88-7.17-7.34-6.21-6.49-4.94
Upgrade
Free Cash Flow Margin
----2956.67%--964.45%
Upgrade
Free Cash Flow Per Share
-0.21-0.22-0.23-0.20-0.21-0.17
Upgrade
Levered Free Cash Flow
-3.49-3.29-3-3.02-1.260.04
Upgrade
Unlevered Free Cash Flow
-3.49-3.29-3-3.02-1.260.04
Upgrade
Change in Working Capital
-0.220.150.53-1.060.490.08
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.